Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Acurx Pharmaceuticals, Inc.
ACXP
Other
Quorum Presence Disclosed
Other
Covid19 Pandemic Uncertainty Disclosure
Reverse Stock Split Effected
Net Loss Reported
Financing Activities Cash Flow Disclosure
Personnel Cost Decrease Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Ipo Or Capital Raising Completion
Institutional Investment
Nyse Listing Disclosure
Stock Option Grant Disclosed
Shares Outstanding Disclosure
Ipo Net Proceeds Disclosure
Use Of Proceeds Disclosure
Warrant Valued Black Scholes
Core
Patient Enrollment Velocity
Other
Covid19 Pandemic Uncertainty Disclosure
Reverse Stock Split Effected
Net Loss Reported
Financing Activities Cash Flow Disclosure
Form S3 Shelf Registration Disclosure
Institutional Investment
Equity Plan Share Reserve Disclosure
Ipo Or Capital Raising Completion
Patient Retention High
Personnel Cost Decrease Disclosure
Interim Data Positive
Use Of Proceeds Disclosure
Capital Raising Uncertainty Disclosed
Core
Clinical Trial Result
Lead Asset Progress